Love that $1 projection! And the risk to reach there is whether or not NAFDAC says IMUN's manufacturing plant has passed inspection? Pretty insane odds IMO. However, there is a bit more risk than just passing the inspection. The drug has to become known and begin to be used and that may not happen immediately. We still might see $1 by the end of the year - I hope so - but I think it depends on more than just marketing approval.
Market Data 
Markets
AI
